Exploring the cost-effectiveness of HPV vaccination in Vietnam: Insights for evidence-based cervical cancer prevention policy

Vaccine

Volumn 26, Issue 32, 2008, Pages 4015-4024

  Kim, Jane J ^a   Kobus, Katie E ^a   Diaz, Mireia ^a,b,c   O'Shea, Meredith ^a   Van Minh, Hoang ^d   Goldie, Sue J ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d HANOI MEDICAL UNIVERSITY   (Viet Nam)

Author keywords

Cervical cancer; Cost effectiveness; Human papillomavirus

Indexed keywords

VIRUS DNA; WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; CANCER PREVENTION; CHILD; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; CRYOSURGERY; DRUG COST; FEMALE; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; INFECTION PREVENTION; MAJOR CLINICAL STUDY; PREVENTIVE MEDICINE; PRIORITY JOURNAL; SCREENING; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VACCINATION; VIRUS INFECTION; WART VIRUS;

ADOLESCENT; ADULT; CHILD; COST-BENEFIT ANALYSIS; EVIDENCE-BASED PRACTICE; FEMALE; HEALTH POLICY; HUMANS; MODELS, ECONOMIC; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; POPULATION SURVEILLANCE; UTERINE CERVICAL NEOPLASMS; VACCINATION; VIETNAM;

EID: 47349103811     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.05.038     Document Type: Article

References (31)

1. Ferlay J., Bray F., Pisani P., and Parkin D.M. Globocan 2002: cancer incidence, mortality, and prevalence worldwide (2004), IARC Press, Lyon
2. Pham T.H.A., Parkin D.M., Nguyen T.H., and Nguyen B.D. Cancer in the population of Hanoi, Vietnam, 1988-1990. Br J Cancer 68 (1993) 1236-1242
3. Nguyen M.Q., Nguyen C.H., and Parkin D.M. Cancer incidence in Ho Chi Minh City, Viet Nam, 1995-1996. Int J Cancer 76 4 (1998) 472-479
4. Pham T.H.A., Nguyen T.H., Herrero R., Vaccarella S., Smith J.S., Nguyen T.T., et al. Human papillomavirus infection among women in South and North Vietnam. Int J Cancer 104 (2003) 213-220
5. Suba E.J., Murphy S.K., Donnelly A.D., Furia L.M., Huynh M.L., and Raab S.S. Systems analysis of real-world obstacles to successful cervical cancer prevention in developing countries. Am J Public Health 96 3 (2006) 480-487
6. Denny L., Quinn M., and Sankaranarayanan R. Chapter 8: screening for cervical cancer in developing countries. Vaccine 24 Suppl. 3 (2006) S71-S77
7. Sankaranarayanan R., Esmy P.O., Rajkumar R., Muwonge R., Swaminathan R., Shanthakumari S., et al. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet 370 9585 (2007) 398-406
8. Mayrand M.H., Duarte-Franco E., Rodrigues I., Walter S.D., Hanley J., Ferenczy A., et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med 357 16 (2007) 1579-1588
9. Goldie S.J., Gaffikin L., Goldhaber-Fiebert J.D., Gordillo-Tobar A., Levin C., Mahe C., et al. Cost-effectiveness of cervical cancer screening in five developing countries. N Engl J Med 353 20 (2005) 2158-2168
10. Clifford G., Franceschi S., Diaz M., Munoz N., and Villa L.L. Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine 24 Suppl. 3 (2006) S26-S34
11. Graham J.D., Corso P.S., Morris J.M., Segui-Gomez M., and Weinstein M.C. Evaluating the cost-effectiveness of clinical and public health measures. Annu Rev Public Health 19 (1998) 125-152
12. Kim J.J., Kuntz K.M., Stout N.K., Mahmud S., Villa L.L., Franco E.L., et al. Multiparameter calibration of a natural history model of cervical cancer. Am J Epidemiol 166 2 (2007) 137-150
13. Goldie S.J., Kim J.J., Kobus K., Goldhaber-Fiebert J.D., Salomon J., O'Shea M.K., et al. Cost-effectiveness of HPV 16, 18 vaccination in Brazil. Vaccine 25 33 (2007) 6257-6270
14. Goldhaber-Fiebert J.D., Stout N.K., Salomon J.A., Kuntz K.M., and Goldie S.J. Cost-effectiveness of cervical cancer screening with human papillomavirus (HPV) DNA testing and HPV-16, 18 vaccination. J Natl Cancer Inst 100 5 (2008) 308-320
15. Clifford G.M., Gallus S., Herrero R., Munoz N., Snijders P.J., Vaccarella S., et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366 9490 (2005) 991-998
16. Parkin DM, Whelan SL, Ferlay J, Storm H. Cancer incidence in five continents, vol. I-VIII. Lyon: IARC CancerBase No. 7; 2005.
17. Clifford G.M., Rana R.K., Franceschi S., Smith J.S., Gough G., and Pimenta J.M. Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev 14 5 (2005) 1157-1164
18. Clifford G.M., Smith J.S., Aguado T., and Franceschi S. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 89 1 (2003) 101-105
19. Clifford G.M., Smith J.S., Plummer M., Munoz N., and Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 88 1 (2003) 63-73
20. Smith J.S., Lindsay L., Hoots B., Keys J., Franceschi S., Winer R., et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 121 3 (2007) 621-632
21. World Development Indicators. World population projections. International Bank for Reconstruction and Development/World Bank Group. http://devdata.worldbank.org.ezp2.harvard.edu/dataonline/. Last accessed December 23, 2007.
22. In: Gold M.R., Siegel J.E., Russel L.B., and Weinstein M.C. (Eds). Cost-effectiveness in health and medicine (1996), Oxford University Press, New York
23. In: Drummond M.F., O'Brien B., Stoddart G.L., and Torrance G.W. (Eds). Methods for the economic evaluation of health care programs (1997), Oxford University Press, New York
24. World Health Organization. Investing in health for economic development. Report of the commission on macroeconomics and health. Geneva: World Health Organization; 2001.
25. Garnett G.P., Kim J.J., French K., and Goldie S.J. Chapter 21: modelling the impact of HPV vaccines on cervical cancer and screening programmes. Vaccine 24 Suppl. 3 (2006) S178-S186
26. Jha P., Bangoura O., and Ranson K. The cost-effectiveness of forty health interventions in Guinea. Health Policy Plan 13 3 (1998) 249-262
27. World Health Organization. WHO immunization surveillance, assessment and monitoring. http://www.who.int/immunization_monitoring/data/data_subject/en/index.ht ml. Last accessed on December 21, 2007.
28. Thang N.M., Bhushan I., Bloom E., and Bonu S. Child immunization in Vietnam: situation and barriers to coverage. J Biosoc Sci 39 (2007) 41-58
29. Ghuman S., Loi V.M., Huy V.T., and Knodel J. Continuity and change in premarital sex in Vietnam. Int Fam Plan Perspect 32 4 (2006) 166-174
30. World Health Organization. The world health report 2006: working together for health. Geneva: World Health Organization. http://www.who.int/whr/2006/annex/en/. Last accessed on December 21, 2007.
31. Kim J.J., Franco E.L., Stout N.K., and Goldie S.J. Author's Reply to Basu S and Galvani AP, Multiparameter calibration of a natural history model of cervical cancer. Am J Epidemiol 166 9 (2007) 983-984